Suchergebnisse - "Parsons, J Kellogg"

PubPharm (345)

31

Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men : Data from a Controlled Trial

enthalten in: The Journal of clinical endocrinology and metabolism | 2019

von Cunningham, G. | Ellenberg, S. | Bhasin, S. | +18

32

Germline testing in those at risk of prostate cancer

enthalten in: The Canadian journal of urology | 2019

von Carroll, P. | Witte, J. | Parsons, J.

33

Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer

enthalten in: European urology oncology | 2019

von Sarkar, R. | Bryant, A. | Parsons, J. | +7

34

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia : AUA Guideline Amendment 2019

enthalten in: The Journal of urology | 2019

von Foster, H. | Dahm, P. | Kohler, T. | +4

CommentIn: J Urol. 2020 Jun;203(6):1219. - PMID 32068489

35

Guidelines should be assessed based on the underlying evidence

enthalten in: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2019

von Carroll, P. | Parsons, J.

CommentOn: CMAJ. 2019 Mar 18;191(11):E297-E298. - PMID 30885967

36

Urological cancers and lifestyle : Nudging patients toward healthy behaviors

enthalten in: Urologic oncology | 2019

von Parsons, J.

37

A genetic hazard score to personalize prostate cancer screening, applied to population data

enthalten in: bioRxiv.org | 2019

von Huynh-Le, M. | Fan, C. | Karunamuni, R. | +60

38

Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer

enthalten in: International journal of radiation oncology, biology, physics | 2019

von Bryant, A. | McKay, R. | Kader, A. | +6

CommentIn: Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):224-225. - PMID 30967233

39

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia : AUA Guideline

enthalten in: The Journal of urology | 2018

von Foster, H. | Barry, M. | Dahm, P. | +10

CommentIn: J Urol. 2019 Feb;201(2):400-403. - PMID 30634379

40

A Randomized, Double-blind, Phase II Trial of PSA-TRICOM (PROSTVAC) in Patients with Localized Prostate Cancer : The Immunotherapy to Prevent Progression on Active Surveillance Study

enthalten in: European urology focus | 2018

von Parsons, J. | Pinto, P. | Pavlovich, C. | +13